These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 12242852)
1. Migraine and its treatment with 5-HT1B/1D agonists (triptans). Moriarty-Sheehan M J Am Acad Nurse Pract; 2002 Aug; 14(8):354-9; quiz 360-2. PubMed ID: 12242852 [TBL] [Abstract][Full Text] [Related]
2. Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials. Ferrari MD; Goadsby PJ; Roon KI; Lipton RB Cephalalgia; 2002 Oct; 22(8):633-58. PubMed ID: 12383060 [TBL] [Abstract][Full Text] [Related]
3. Patient treatment preferences and the 5-HT1B/1D agonists. Ryan RE Arch Intern Med; 2001 Nov; 161(21):2545-53. PubMed ID: 11718585 [TBL] [Abstract][Full Text] [Related]
4. Triptans: over the migraine. Cologno D; Mazzeo A; Lecce B; Mundi C; Petretta V; Casucci G; d'Onofrio F Neurol Sci; 2012 May; 33 Suppl 1():S193-8. PubMed ID: 22644202 [TBL] [Abstract][Full Text] [Related]
5. Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials. Ferrari MD; Roon KI; Lipton RB; Goadsby PJ Lancet; 2001 Nov; 358(9294):1668-75. PubMed ID: 11728541 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic evaluation of frovatriptan. Negro A; Lionetto L; Casolla B; Lala N; Simmaco M; Martelletti P Expert Opin Drug Metab Toxicol; 2011 Nov; 7(11):1449-58. PubMed ID: 21929465 [TBL] [Abstract][Full Text] [Related]
7. The safety of triptans in the treatment of patients with migraine. Jamieson DG Am J Med; 2002 Feb; 112(2):135-40. PubMed ID: 11835952 [TBL] [Abstract][Full Text] [Related]
8. An economic evaluation of rizatriptan in the treatment of migraine. Thompson M; Gawel M; Desjardins B; Ferko N; Grima D Pharmacoeconomics; 2005; 23(8):837-50. PubMed ID: 16097844 [TBL] [Abstract][Full Text] [Related]
9. Migraine headache recurrence: relationship to clinical, pharmacological, and pharmacokinetic properties of triptans. Géraud G; Keywood C; Senard JM Headache; 2003 Apr; 43(4):376-88. PubMed ID: 12656709 [TBL] [Abstract][Full Text] [Related]
11. Naratriptan: an alternative for migraine. Dulli DA Ann Pharmacother; 1999 Jun; 33(6):704-11. PubMed ID: 10410185 [TBL] [Abstract][Full Text] [Related]
12. Migraine: diagnosis and management. Goadsby PJ Intern Med J; 2003; 33(9-10):436-42. PubMed ID: 14511196 [TBL] [Abstract][Full Text] [Related]
13. Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy. Tfelt-Hansen P; De Vries P; Saxena PR Drugs; 2000 Dec; 60(6):1259-87. PubMed ID: 11152011 [TBL] [Abstract][Full Text] [Related]
14. Usage of triptans among migraine patients: an audit in nine GP practices. Williams D; Cahill T; Dowson A; Fearon H; Lipscombe S; O'Sullivan E; Rees T; Strang C; Valori A; Watson D Curr Med Res Opin; 2002; 18(1):1-9. PubMed ID: 11999139 [TBL] [Abstract][Full Text] [Related]
15. Almotriptan: a review of its use in migraine. Keam SJ; Goa KL; Figgitt DP Drugs; 2002; 62(2):387-414. PubMed ID: 11817980 [TBL] [Abstract][Full Text] [Related]
16. [Triptans in migraine--here and now (15 years after they were implemented in therapy)]. Prusiński A; Rozniecki JJ Neurol Neurochir Pol; 2005; 39(4 Suppl 1):S68-77. PubMed ID: 16419574 [TBL] [Abstract][Full Text] [Related]
18. [Triptans--pivotal event in migraine treatment]. Lusić I; Bilić I Acta Med Croatica; 2008 May; 62(2):173-8. PubMed ID: 18710081 [TBL] [Abstract][Full Text] [Related]
19. Safety and rational use of the triptans. Tepper SJ Med Clin North Am; 2001 Jul; 85(4):959-70. PubMed ID: 11480267 [TBL] [Abstract][Full Text] [Related]